Agile Therapeutics has paid-off the remainder of its debt facility with Perceptive Advisors. This significant milestone completes the repayment schedule contemplated by the Loan Agreement between the Company and Perceptive, which originated in 2020 and ended as of March 11, 2024. The Company remains focused on growing Twirla and advancing the Company’s business plan.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AGRX:
- Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
- Agile Therapeutics Secures Funding Through Warrant Transactions
- Agile Therapeutics announces exercise of warrants for $4.8M gross proceeds
- Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
- Agile Therapeutics Gains Extension on Loan and Nasdaq Compliance
